日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

以染色质为中心的遗传和化学筛选发现 BRPF1 是紫杉醇耐药三阴性乳腺癌的一个可靶向的脆弱点

Yedier-Bayram Ozlem, Cingöz Ahmet, Yilmaz Ebru, Aksu Ali Cenk, Esin Beril, Degirmenci Nareg, Cavga Ayse Derya, Dedeoğlu Beyza, Cevatemre Buse, Syed Hamzah, Philpott Martin, Cribbs Adam P, Oppermann Udo, Lack Nathan A, Acilan Ceyda, Onder Tamer T, Bagci-Onder Tugba

Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.

表观药物筛选发现 I 型 PRMT 抑制剂可调节溶酶体胞吐作用和癌症中的药物敏感性

Sergi Baris, Yuksel-Catal Neslihan, Ozcan Selahattin Can, Syed Hamzah, Duvvuri Umamaheswar, Kiselyov Kirill, Acilan Ceyda

Menin-driven mTOR signaling sustains taxane resistance in CRPC and reveals a targetable vulnerability for combination therapy

Menin 驱动的 mTOR 信号通路维持 CRPC 中的紫杉烷类药物耐药性,并揭示了联合治疗的一个可靶向的脆弱性。

Bulut, Ipek; Cevatemre, Buse; Yuksel-Catal, Neslihan; Syed, Hamzah; Onder, Tamer; Acilan, Ceyda

Understanding the Modes of Action of β-Ketoiminato Iridium(III) Complexes in Cancer Cells

了解β-酮亚胺铱(III)配合物在癌细胞中的作用机制

Stringer, Tameryn; Yildirim, Büşra; Sergi, Baris; Hofmann, Benjamin J; Lee, Yi-Hsuan; Acilan, Ceyda; Lord, Rianne M

Keep Calm and Carry on with Extra Centrosomes

保持冷静,继续使用额外的中心体

Kalkan, Batuhan Mert; Ozcan, Selahattin Can; Quintyne, Nicholas J; Reed, Samantha L; Acilan, Ceyda

Characterizing the Cellular Response to Nitrogen-Doped Carbon Nanocups

表征细胞对氮掺杂碳纳米杯的反应

Griffith, Amber S; Zhang, Thomas D; Burkert, Seth C; Adiguzel, Zelal; Acilan, Ceyda; Star, Alexander; Saunders, William S